(Q40616709)

English

In vitro induction of carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes by dendritic cells transduced with recombinant adenoviruses

scientific article published on December 12, 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

22 September 2017

In vitro induction of carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes by dendritic cells transduced with recombinant adenoviruses (English)

1 reference

Europe PubMed Central

22 September 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14615150

1 April 2024

molecular medicine

1 reference

10.1016/S0264-410X(03)00569-3

https://api.crossref.org/works/10.1016/S0264-410X(03)00569-3

1 April 2024

author name string

Hyun-Il Cho

1

1 reference

Europe PubMed Central

22 September 2017

Hye-Jin Kim

2

1 reference

Europe PubMed Central

22 September 2017

Seoug-Taek Oh

3

1 reference

Europe PubMed Central

22 September 2017

Tai-Gyu Kim

4

1 reference

Europe PubMed Central

22 September 2017

language of work or name

0 references

publication date

1 December 2003

1 reference

Europe PubMed Central

22 September 2017

12 December 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14615150

1 April 2024

full work available at URL

https://api.elsevier.com/content/article/PII:S0264410X03005693?httpAccept=text/xml

1 reference

10.1016/S0264-410X(03)00569-3

https://api.crossref.org/works/10.1016/S0264-410X(03)00569-3

1 April 2024

https://api.elsevier.com/content/article/PII:S0264410X03005693?httpAccept=text/plain

1 reference

10.1016/S0264-410X(03)00569-3

https://api.crossref.org/works/10.1016/S0264-410X(03)00569-3

1 April 2024

1 reference

Europe PubMed Central

22 September 2017

22

1 reference

Europe PubMed Central

22 September 2017

2

1 reference

Europe PubMed Central

22 September 2017

224-236

1 reference

Europe PubMed Central

22 September 2017

Carcinoembryonic antigen gene family: molecular biology and clinical perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900569-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunology and immunotherapy of human cancer: present concepts and clinical developments

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900569-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Cutting edge: CD4+ T cell control of CD8+ T cell reactivity to a model tumor antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900569-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Report from the International Union Against Cancer (UICC) Tumor Biology Committee: UICC workshop on the use of dendritic cells in cancer clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900569-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Dendritic cell based tumor vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900569-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Dendritic cells and the control of immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900569-3

7 January 2021

based on heuristic

inferred from DOI database lookup

CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900569-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900569-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900569-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Bone marrow-generated dendritic cells pulsed with tumor extracts or tumor RNA induce antitumor immunity against central nervous system tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900569-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Regression of tumors in mice vaccinated with professional antigen-presenting cells pulsed with tumor extracts

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900569-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Endogenous presentation of a nascent antigenic epitope to CD8+ CTL is more efficient than exogenous presentation

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900569-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Dendritic cells genetically modified with an adenovirus vector encoding the cDNA for a model antigen induce protective and therapeutic antitumor immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900569-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Gene-modified dendritic cells for use in tumor vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900569-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Delayed cutaneous hypersensitivity reaction to carcinoembryonic antigen in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900569-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Antitumor Activity and Immune Responses Induced by a Recombinant Carcinoembryonic Antigen-Vaccinia Virus Vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900569-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Diversified prime and boost protocols using recombinant vaccinia virus and recombinant non-replicating avian pox virus to enhance T-cell immunity and antitumor responses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900569-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Generation of human cytotoxic T cells specific for human carcinoembryonic antigen epitopes from patients immunized with recombinant vaccinia-CEA vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900569-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I study in cancer patients of a replication-defective avipox recombinant vaccine that expresses human carcinoembryonic antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900569-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900569-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Carcinoembryonic antigen (CEA) presentation and specific T cell-priming by human dendritic cells transfected with CEA-mRNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900569-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Construction of a defective adenovirus vector expressing the pseudorabies virus glycoprotein gp50 and its use as a live vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900569-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Proliferating dendritic cell progenitors in human blood

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900569-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunomodulation therapy in colorectal carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900569-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Carcinoembryonic antigen as a target for therapeutic anticancer vaccines: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900569-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Longitudinal follow-up of cellular and humoral immunity induced by recombinant adenovirus-mediated gene therapy in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900569-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Novel centrifugal method for simple and highly efficient adenovirus-mediated green fluorescence protein gene transduction into human monocyte-derived dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900569-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Prolonged maturation and enhanced transduction of dendritic cells migrated from human skin explants after in situ delivery of CD40-targeted adenoviral vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900569-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Carcinoembryonic antigen is anchored to membranes by covalent attachment to a glycosylphosphatidylinositol moiety: identification of the ethanolamine linkage site

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900569-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Cross-presentation by dendritic cells of tumor antigen expressed in apoptotic recombinant canarypox virus-infected dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900569-3

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro priming with adenovirus/gp100 antigen-transduced dendritic cells reveals the epitope specificity of HLA-A*0201-restricted CD8+ T cells in patients with melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900569-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Gene therapy with recombinant adenovirus vectors: evaluation of the host immune response

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900569-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Construction and characterization of adenovirus serotype 5 packaged by serotype 3 hexon

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900569-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Characterization of factors involved in modulating persistence of transgene expression from recombinant adenovirus in the mouse lung

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900569-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Adenovirally transduced dendritic cells induce bispecific cytotoxic T lymphocyte responses against adenovirus and cytomegalovirus pp65 or against adenovirus and Epstein-Barr virus EBNA3C protein: a novel approach for immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900569-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Helper-dependent adenoviral vectors efficiently express transgenes in human dendritic cells but still stimulate antiviral immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900569-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Dendritic cells transduced with an adenoviral vector encoding a model tumor-associated antigen for tumor vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900569-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Murine dendritic cells infected with adenovirus vectors show signs of activation

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900569-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Overcoming inhibition of antibody responses to a malaria recombinant vaccinia virus caused by prior exposure to wild type virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900569-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Vaccination with two different vaccinia recombinant viruses: long-term inhibition of secondary vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900569-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I study in advanced cancer patients of a diversified prime-and-boost vaccination protocol using recombinant vaccinia virus and recombinant nonreplicating avipox virus to elicit anti-carcinoembryonic antigen immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900569-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction of Tumor-Specific Cytotoxic T Lymphocytes in Cancer Patients by Autologous Tumor RNA-Transfected Dendritic Cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900569-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900569-3

7 January 2021

based on heuristic

inferred from DOI database lookup

MHC class-I-restricted auto-tumor-specific CD4+CD8- T-cell clones established from autologous mixed lymphocyte-tumor-cell culture (MLTC)

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900569-3

7 January 2021

based on heuristic

inferred from DOI database lookup

CD4+ class I-restricted T cells specific for HIV gp160 315-329

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900569-3

7 January 2021

based on heuristic

inferred from DOI database lookup

A Phase I study of active immunotherapy with carcinoembryonic antigen peptide (CAP-1)-pulsed, autologous human cultured dendritic cells in patients with metastatic malignancies expressing carcinoembryonic antigen

10

1 reference

10.1016/S0264-410X(03)00569-3

https://api.crossref.org/works/10.1016/S0264-410X(03)00569-3

1 April 2024

Specific cytolytic T-cell responses to human CEA from patients immunized with recombinant avipox-CEA vaccine

24

1 reference

10.1016/S0264-410X(03)00569-3

https://api.crossref.org/works/10.1016/S0264-410X(03)00569-3

1 April 2024

The infection of human dendritic cells with recombinant avipox vectors expressing a costimulatory molecule transgene (CD80) to enhance the activation of antigen-specific cytolytic T cells

25

1 reference

10.1016/S0264-410X(03)00569-3

https://api.crossref.org/works/10.1016/S0264-410X(03)00569-3

1 April 2024

Induction of tumor immunity and cytotoxic T lymphocyte responses using dendritic cells transfected with messenger RNA amplified from tumor cells

27

1 reference

10.1016/S0264-410X(03)00569-3

https://api.crossref.org/works/10.1016/S0264-410X(03)00569-3

1 April 2024

A comparison of gene transfer methods in human dendritic cells

36

1 reference

10.1016/S0264-410X(03)00569-3

https://api.crossref.org/works/10.1016/S0264-410X(03)00569-3

1 April 2024

A triad of costimulatory molecules synergize to amplify T-cell activation

55

1 reference

10.1016/S0264-410X(03)00569-3

https://api.crossref.org/works/10.1016/S0264-410X(03)00569-3

1 April 2024

Enhanced activation of human T cells via avipox vector-mediated hyperexpression of a triad of costimulatory molecules in human dendritic cells

56

1 reference

10.1016/S0264-410X(03)00569-3

https://api.crossref.org/works/10.1016/S0264-410X(03)00569-3

1 April 2024

Phase I trial of a recombinant vaccinia virus encoding carcinoembryonic antigen in metastatic adenocarcinoma: comparison of intradermal versus subcutaneous administration

57

1 reference

10.1016/S0264-410X(03)00569-3

https://api.crossref.org/works/10.1016/S0264-410X(03)00569-3

1 April 2024

Identifiers

10.1016/S0264-410X(03)00569-3

1 reference

Europe PubMed Central

22 September 2017

1 reference

Europe PubMed Central

22 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40616709&oldid=2116356340"